Cures Within Reach new funding call: Clinical trials to validate AI-driven drug repurposing
2025-07-31 15:30 - 16:30 (Europe/Paris) | Zoom
We are excited to announce our upcoming webinar in collaboration with Beacon for rare diseases and Cures Within Reach!
Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data, AI can help identify existing medicines that might work for different conditions – something particularly valuable in rare diseases.
However, do AI-generated predictions actually work when tested in real-life clinical trials?
Cures Within Reach is helping to explore this question through a new funding call. They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas, with a preference for rare disease!
You can visit https://bit.ly/cwrrfps for more information.
In this webinar, we’ll cover:

A breakdown of what this funding call is about
Advice from Cures Within Reach on what makes a strong application
How patient groups can get involved in applications
A practical example of a patient group contributing to an AI-led initiative
The opportunity to ask any questions you might have to the Cures Within Reach team

If you’d like to learn more, please visit Beacon’s website!
To get your ticket, click here.
Who is this webinar for?
This session is open to any patient group interested in learning more about this unique funding opportunity – including patient groups already involved in AI-driven clinical research, as well as those looking to better understand how AI can support drug repurposing.
No technical AI experience is needed – the session is designed to be accessible regardless of where you are on your journey!

IP Strategies for Repurposing
2025-11-21 14:00 - 15:30 | Zoom
Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success!
Not sure where to start with intellectual property (IP) in your drug repurposing project? REMEDi4ALL’s Repurposing Academy is here to guide you!
Join us for our upcoming webinar where we will explore the importance of considering IP as part of your broader drug repurposing strategy.
We’ll discuss common challenges you may encounter and key considerations to keep in mind throughout your repurposing project. Additionally, we’ll outline practical steps for securing IP protection for repurposed drugs and show how a strong IP strategy can help drive your project forward.
To get your ticket, click here!

REMEDi4ALL Drug Repurposing Bootcamp for Academics
2026-03-11 - 2026-05-12 | Hinxton Hall, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom
The REMEDi4ALL Drug Repurposing Bootcamp for Academics, held at the Wellcome Genome Campus in Cambridge, aims to support researchers embarking on this journey. This pilot training course will provide face to face training to explain the full drug repurposing pathway, helping researchers understand the steps involved in turning a repurposing hypothesis into a product capable of delivering real impact to patients.
Learn more and apply now by clicking here!
